Signify Research July 25, 2019
Alex Green

This morning saw Health Catalyst announce that it expects its common stock to begin trading on the Nasdaq Global Select Market today. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximised the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive future success. Here’s our take on the company’s journey to this point and its future opportunities and challenges as it transitions from start-up to a publicly traded company.

The Journey to IPO

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Big Data, Digital Health, Investments, Technology, Trends
Analyzing OpenAI’s investment strategy: Where the ChatGPT maker is betting on AI disruption
Imperative Care closes potential $150M Series E and more digital health fundings
TRiCares raises $50m to trial tricuspid heart valve replacement system
Thoughtful AI Launches Human-Capable AI Agents, Raises $20M in New Funding
Fueled With $100M, Autobahn Therapeutics Gears Up for Depression Drug Clinical Trials

Share This Article